GlassScriptPhysician profile
Jeffrey Brian Smith
NPI 1609863018
$1,297.74
in general payments reported to CMS, 2019-2025
17 companies · $281 in 2025
The $281 reported for 2025 was more than what 83% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $47.01 · 2021: $165 · 2022: $266 · 2023: $263 · 2024: $156 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $189.36 | 2019-2025 | |
| Dermavant Sciences, INC. | $148.43 | 2023 | Vtama |
| Supernus Pharmaceuticals, INC. | $130.53 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $121.79 | 2021-2025 | Gardasil 9, M-M-R II, Enflonsia |
| Tris Pharma INC | $88.93 | 2022-2025 | Dyanavel Xr |
| Seqirus USA INC | $88.67 | 2022-2025 | Flucelvax |
| Corium, LLC | $80.18 | 2022-2023 | Azstarys |
| Cranial Technologies, INC | $69.68 | 2023-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $67.70 | 2019-2020 | |
| Sobi, INC | $65.28 | 2020-2023 | |
| Kaleo, INC. | $57.92 | 2019-2022 | |
| Glaxosmithkline, LLC. | $39.70 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $38.54 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $37.38 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $32.12 | 2025 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $22.94 | 2025 | Aptima |
| Sanofi-Aventis U.S. LLC | $18.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.